Showing 1 - 2 results of 2 for search 'Wanxian Zeng', query time: 0.02s
Refine Results
-
1
First-line nivolumab plus ipilimumab for unresectable MPM in China: a cost-effectiveness analysis by Liu Yang, Xiaobing Song, Wanxian Zeng, Zhiwei Zheng, Wenqiang Lin
Published 2023-10-01
Article -
2
Cost-effectiveness analysis of elacestrant versus standard endocrine therapy for second-/third-line treatment of patients with HR+/HER2- advanced or metastatic breast cancer: a US... by Wanxian Zeng, Wanxian Zeng, Xueqiong Cao, Xueqiong Cao, Jingwen Lin, Jingwen Lin, Bin Zheng, Bin Zheng, Na Li, Na Li, Maobai Liu, Maobai Liu, Hongfu Cai, Hongfu Cai
Published 2023-12-01
Article